Xueyu Man

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer

Ming Jiang, Zhenlei Zhang, Wenjuan Li et al. · Journal of Medicinal Chemistry · 2022 · 65 citations

Pharmacy, Oncology, Pharmacology +17

Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin

Wenjuan Li, Shanhe Li, Zhenlei Zhang et al. · Journal of Medicinal Chemistry · 2023 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer

Xueyu Man, Tongfu Yang, Wenjuan Li et al. · Journal of Medicinal Chemistry · 2023 · 43 citations

Pharmacy, Medicinal Chemistry, Oncology +17

Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis

Wenjuan Li, Shanhe Li, Gang Xu et al. · Journal of Medicinal Chemistry · 2023 · 39 citations

Pharmacy, Oncology, Pharmacology +17

Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual‐Agent Combination Therapy for Cancer

Xueyu Man, Wenjuan Li, Minghui Zhu et al. · Angewandte Chemie International Edition · 2024 · 33 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17